Merck & Co., Inc. (MRK): A Bull Case Theory

We came across a bullish thesis on Merck & Co., Inc. (MRK) on Substack by Jimmy Investor. In this article, we will summarize the bulls’ thesis on MRK. Merck & Co., Inc. (MRK)'s share was trading at $94.79 as of March 17^th. MRK’s trailing and forward P/E were 14.06 and 10.53 respectively according to Yahoo Finance.

[caption id="attachment_1200544" align="aligncenter" width="768"] A medical staff in white coats monitoring the progress of cancer immunotherapy trials.[/caption]

Merck & Co. (MRK) stands out as a global pharmaceutical player with a robust business model built on...